Literature DB >> 26602384

Wnt/β-catenin signaling inhibits FBXW7 expression by upregulation of microRNA-770 in hepatocellular carcinoma.

Wen-Jie Wu1, Jia Shi1, Gang Hu2, Xin Yu2, Han Lu3, Ming-Liang Yang4, Bin Liu5, Zhi-Xiang Wu6.   

Abstract

FBXW7 (F-box and WD repeat domain-containing 7) is the F-box protein component of a Skp1-Cul1-F-box protein-type (SCF-type) ubiquitin ligase. Previous studies have shown that FBXW7 serves as a tumor suppressor and is frequently downregulated in many types of human neoplasms. However, the molecular mechanisms for its downregulation remain poorly understood. Hyperactivation of Wnt/β-catenin signaling pathway is viewed as crucial for tumorigenesis, including hepatocellular carcinoma (HCC). In the present study, we show that protein levels, but not message RNA, of FBXW7 were suppressed by Wnt3a treatment or transfection of a constitutively activated β-catenin in HCC cells. Besides, microRNA-770 was identified as an important downstream target of Wnt/β-catenin signaling, to inhibit FBXW7 expression through targeting its 3'-untranslated region. Thus, our results suggest a previously unknown Wnt/β catenin-miR-770-FBXW7 molecular network in the HCC development.

Entities:  

Keywords:  FBXW7; Hepatocellular carcinoma (HCC); MicroRNA-770; Wnt/β catenin

Mesh:

Substances:

Year:  2015        PMID: 26602384     DOI: 10.1007/s13277-015-4452-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  28 in total

1.  The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.

Authors:  Kuppusamy Balamurugan; Ju-Ming Wang; Hsin-Hwa Tsai; Shikha Sharan; Miriam Anver; Robert Leighty; Esta Sterneck
Journal:  EMBO J       Date:  2010-11-12       Impact factor: 11.598

2.  Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver.

Authors:  Ichiro Onoyama; Atsushi Suzuki; Akinobu Matsumoto; Kengo Tomita; Hideki Katagiri; Yuichi Oike; Keiko Nakayama; Keiichi I Nakayama
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

3.  Genistein down-regulates miR-223 expression in pancreatic cancer cells.

Authors:  Jia Ma; Long Cheng; Hao Liu; Jing Zhang; Ying Shi; Fanpeng Zeng; Lucio Miele; Fazlul H Sarkar; Jun Xia; Zhiwei Wang
Journal:  Curr Drug Targets       Date:  2013-09       Impact factor: 3.465

4.  Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene.

Authors:  Jian-Hua Mao; Jesus Perez-Losada; Di Wu; Reyno Delrosario; Ryosuke Tsunematsu; Keiichi I Nakayama; Ken Brown; Sheila Bryson; Allan Balmain
Journal:  Nature       Date:  2004-12-09       Impact factor: 49.962

5.  SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock.

Authors:  Ray-Chang Wu; Qin Feng; David M Lonard; Bert W O'Malley
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

6.  The ubiquitin ligase SCFFbw7 antagonizes apoptotic JNK signaling.

Authors:  Abdolrahman S Nateri; Lluís Riera-Sans; Clive Da Costa; Axel Behrens
Journal:  Science       Date:  2004-01-22       Impact factor: 47.728

7.  hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53.

Authors:  Takashi Kimura; Mitsukazu Gotoh; Yusuke Nakamura; Hirofumi Arakawa
Journal:  Cancer Sci       Date:  2003-05       Impact factor: 6.716

Review 8.  Deubiquitinases in cancer.

Authors:  Rongbin Wei; Xiaodong Liu; Weixin Yu; Tianshu Yang; Wenping Cai; Junjun Liu; Xiao Huang; Guo-tong Xu; Shouliang Zhao; Jianhua Yang; Shangfeng Liu
Journal:  Oncotarget       Date:  2015-05-30

9.  Fbw7 repression by hes5 creates a feedback loop that modulates Notch-mediated intestinal and neural stem cell fate decisions.

Authors:  Rocio Sancho; Sophia M Blake; Christian Tendeng; Bruce E Clurman; Julian Lewis; Axel Behrens
Journal:  PLoS Biol       Date:  2013-06-11       Impact factor: 8.029

Review 10.  Aberrant regulation of FBW7 in cancer.

Authors:  Lixia Wang; Xiantao Ye; Yueyong Liu; Wenyi Wei; Zhiwei Wang
Journal:  Oncotarget       Date:  2014-04-30
View more
  11 in total

1.  Extensive miRNA expression analysis in craniopharyngiomas.

Authors:  Jill Samis; Elio F Vanin; Simone Treiger Sredni; Maria de Fátima de Bonaldo; Fabricio F Costa; Tadanori Tomita; Reema Habiby; Donald Zimmerman; Marcelo B Soares
Journal:  Childs Nerv Syst       Date:  2016-06-07       Impact factor: 1.475

2.  miRNA-770-5p expression is upregulated in patients with type 2 diabetes and miRNA-770-5p knockdown protects pancreatic β-cell function via targeting BAG5 expression.

Authors:  Min Wang; Jilou Wei; Ting Ji; Kui Zang
Journal:  Exp Ther Med       Date:  2021-04-22       Impact factor: 2.447

3.  Identifying Novel Glioma-Associated Noncoding RNAs by Their Expression Profiles.

Authors:  Alenka Matjašič; Mojca Tajnik; Emanuela Boštjančič; Mara Popović; Boštjan Matos; Damjan Glavač
Journal:  Int J Genomics       Date:  2017-09-12       Impact factor: 2.326

Review 4.  The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer.

Authors:  Yin Peng; Xiaojing Zhang; Xianling Feng; Xinmim Fan; Zhe Jin
Journal:  Oncotarget       Date:  2017-02-21

5.  MicroRNA-770 affects proliferation and cell cycle transition by directly targeting CDK8 in glioma.

Authors:  Jun-Feng Zhang; Jian-Shui Zhang; Zhao-Hua Zhao; Peng-Bo Yang; Sheng-Feng Ji; Nan Li; Qin-Dong Shi; Jing Tan; Xi Xu; Cang-Bao Xu; Ling-Yu Zhao
Journal:  Cancer Cell Int       Date:  2018-12-03       Impact factor: 5.722

6.  Interplay of miRNAs and Canonical Wnt Signaling Pathway in Hepatocellular Carcinoma.

Authors:  Xiaobo Nie; Yiran Liu; Wei-Dong Chen; Yan-Dong Wang
Journal:  Front Pharmacol       Date:  2018-06-21       Impact factor: 5.810

7.  Involvement of miR-770-5p in trastuzumab response in HER2 positive breast cancer cells.

Authors:  Senem Noyan; Hakan Gurdal; Bala Gur Dedeoglu
Journal:  PLoS One       Date:  2019-04-22       Impact factor: 3.240

8.  Analysis of microarray data for identification of key microRNA signatures in glioblastoma multiforme.

Authors:  Sanu K Shaji; Damu Sunilkumar; N V Mahalakshmi; Geetha B Kumar; Bipin G Nair
Journal:  Oncol Lett       Date:  2019-06-24       Impact factor: 2.967

9.  MicroRNA-421 confers paclitaxel resistance by binding to the KEAP1 3'UTR and predicts poor survival in non-small cell lung cancer.

Authors:  Fu-Gang Duan; Mei-Fang Wang; Ya-Bing Cao; Run-Ze Li; Xing-Xing Fan; Imran Khan; Huan-Ling Lai; Yi-Zhong Zhang; Wendy Wen-Luan Hsiao; Xiao-Jun Yao; Qi-Biao Wu; Liang Liu; Yi-Jun Tang; Elaine Lai-Han Leung
Journal:  Cell Death Dis       Date:  2019-10-28       Impact factor: 8.469

10.  Aberrant methylation of WD-repeat protein 41 contributes to tumour progression in triple-negative breast cancer.

Authors:  Han Wang; Dan Wu; Liangliang Cai; Xiaohong Li; Zhiming Zhang; Shuai Chen
Journal:  J Cell Mol Med       Date:  2020-05-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.